Henderson S. T., Poirier J. (2011). Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study, BMC Med Genet, 12, 137. En savoir plus.

Leduc V., Domenger D., De Beaumont L., Lalonde D., Belanger-Jasmin S., Poirier J. (2011). Function and comorbidities of apolipoprotein e in Alzheimer's disease, Int J Alzheimers Dis, 2011, 974361. En savoir plus.

Leduc V., Legault V., Dea D., Poirier J. (2011). Normalization of gene expression using SYBR green qPCR: A case for paraoxonase 1 and 2 in Alzheimer's disease brains, J Neurosci Methods, 200(1), 14-19. En savoir plus.

Poirier J., Gauthier S. (2011). La Maladie D’Alzheimer: Le Guide , .

Poirier J., Semple H., Davies J., Lapointe R., Dziwenka M., Hiltz M., Mujibi D. (2011). Double-blind, vehicle-controlled randomized twelve-month neurodevelopmental toxicity study of common aluminum salts in the rat, Neuroscience, 193, 338-362. En savoir plus.